Given the above observations that pamiparib treatment induces PD-L1 expressions, we next investigated whether blocking PD-L1 could enhance the anti-cancer effects of pamiparib in pancreatic cancer. This evidence concerns the gene CD274 and familial pancreatic carcinoma.